These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 90654)

  • 1. Characterization of the antigenic determinants of cholera toxin subunits.
    Markel DE; Hejtmancik KE; Peterson JW; Martin FB; Kurosky A
    Infect Immun; 1979 Aug; 25(2):615-26. PubMed ID: 90654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic specificity of neutralizing antibody to cholera toxin.
    Peterson JW; Hejtmancik KE; Markel DE; Craig JP; Kurosky A
    Infect Immun; 1979 Jun; 24(3):774-9. PubMed ID: 89089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin.
    Gilligan PH; Brown JC; Robertson DC
    Infect Immun; 1983 Nov; 42(2):683-91. PubMed ID: 6196292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay for the antigenic determinants of cholera toxin and its components.
    Hejtmancik KE; Peterson JW; Markel DE; Kurosky A
    Infect Immun; 1977 Sep; 17(3):621-8. PubMed ID: 71268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of hybridoma cell lines and characterization of monoclonal antibodies against cholera enterotoxin and its subunits.
    Robb M; Nichols JC; Whoriskey SK; Murphy JR
    Infect Immun; 1982 Oct; 38(1):267-72. PubMed ID: 6183210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of monoclonal antibodies to cholera toxin.
    Remmers EF; Colwell RR; Goldsby RA
    Infect Immun; 1982 Jul; 37(1):70-6. PubMed ID: 6179882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response related to the molecular structure of a peptide from the cholera toxin B subunit.
    Halimi H; Rivaille P
    Vaccine; 1993 Sep; 11(12):1233-9. PubMed ID: 7504858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, function, and antigenicity of cholera toxin.
    Markel DE; Hejtmancik KE; Peterson JW; Kurosky A
    J Supramol Struct; 1979; 10(2):137-49. PubMed ID: 88548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.
    Jacob CO; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7611-5. PubMed ID: 6584874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against experimental cholera by oral or parenteral immunization.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):594-8. PubMed ID: 546789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
    Häse CC; Thai LS; Boesman-Finkelstein M; Mar VL; Burnette WN; Kaslow HR; Stevens LA; Moss J; Finkelstein RA
    Infect Immun; 1994 Aug; 62(8):3051-7. PubMed ID: 8039872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
    Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
    Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of El Tor cholera enterotoxins and comparisons with classical toxin.
    Dubey RS; Lindblad M; Holmgren J
    J Gen Microbiol; 1990 Sep; 136(9):1839-47. PubMed ID: 1704409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomeric structure of cholera toxin: characteristics of the H and L subunits.
    Holmgren J; Lonnroth I
    J Gen Microbiol; 1975 Jan; 86(1):49-65. PubMed ID: 803547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit.
    Fontana MR; Manetti R; Giannelli V; Magagnoli C; Marchini A; Olivieri R; Domenighini M; Rappuoli R; Pizza M
    Infect Immun; 1995 Jun; 63(6):2356-60. PubMed ID: 7768621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model.
    Boustanshenas M; Bakhshi B; Ghorbani M
    J Appl Microbiol; 2013 Feb; 114(2):509-15. PubMed ID: 23082752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli.
    Clements JD; Finkelstein RA
    Infect Immun; 1978 Dec; 22(3):709-13. PubMed ID: 83301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migrating action-potential complex activity in absence of fluid production is produced by B subunit of cholera enterotoxin.
    Sinar DR; Charles LG; Burns TW
    Am J Physiol; 1982 Jan; 242(1):G47-51. PubMed ID: 7058898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.